Dr Kiran Mazumdar‑Shaw

Biotech Entrepreneur | Global Business Leader | Philanthropist | Healthcare Innovator

Innovation is both about doing different things as well as doing things differently.¹

— Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw was born in 1953 in Bangalore in the southern Indian state of Karnataka. She spent her childhood between two worlds: the sights and smells of the brewery compound where her family lived, and the local science museum, whose exhibits captured her imagination.²  Surrounded by these influences and encouraged by her father to pursue her ambitions with the same determination expected of her brothers, her curiosity evolved into a career that would eventually place her among the world’s leading figures in biotechnology.

Kiran studied at Bishop Cotton Girls School in Bangalore before pursuing an honours degree in zoology at Bangalore University, where she graduated with top rank. When she was unable to secure a merit seat in medical school, she chose instead to study fermentation science—an emerging field that combined biology, chemistry, and industry.

At 21, she travelled to Australia, to earn a Post-Graduate Diploma in Malting and Brewing at Ballarat College of Advanced Education (now Federation University Australia). She later described this period as “a defining time” in her life when she learned to be self‑reliant, both as a young woman in a male‑dominated classroom and as someone pursuing a career few women would have considered. ³ 

Kiran topped the course and returned to India in 1975 as a Master Brewer, confident she would secure work at a leading brewery. Despite her qualifications, Kiran encountered gender bias barriers. She repeatedly encountered the opinion that “brewing is a man’s job” ⁴ and was unable to secure a job as a Brewmaster. 

Realising she needed to adapt, Kiran sought new possibilities in Scotland. However, before she could make that move, a chance meeting in New Delhi changed the course of her life. She met Irish entrepreneur Leslie Auchincloss, founder of Biocon Biochemicals, who was seeking a partner to source enzymes from India. He persuaded 25-year-old Kiran to pursue the far riskier dream of building a biotechnology enterprise in India. Despite her initial reluctance, Kiran launched India’s first biotechnology company in a garage with an initial investment of ten thousand rupees (approximately $1,200 at the time).⁵  Her intention was to develop specialty enzymes to replace polluting chemical processes with eco-friendly enzymatic bio-processes.

Starting a science-based business as a woman in a male-dominated industry in India was challenging. Kiran initially struggled to attract employees and to establish credibility with banks and investors who saw her as a high risk because of her gender.

“When I started Biocon, I was seen as a young woman who lacked credibility, lacked experience, and lacked financial means. All I had was self-belief and grit. That’s all you need to get started!” 

Kiran persevered and went on to build India’s largest enzymes company. 

Building on the success of the enzymes business, Kiran pivoted to biopharmaceuticals in the late 1990s with a clear purpose: to apply the power of science and technology to bridge healthcare inequities by developing affordable, life‑saving medicines for chronic diseases. 

Kiran dedicated herself to improving healthcare access, particularly for underserved communities. She has supported rural health centers, implemented telemedicine programs, and helped establish the Mazumdar‑Shaw Cancer Centre, which provides affordable cancer treatment. She also mentors scientists and entrepreneurs worldwide, encouraging innovations that benefit society.

Under Kiran’s visionary leadership Biocon has grown into a global biopharmaceutical enterprise with multi‑billion‑dollar revenues and market valuation, producing affordable yet cutting-edge medicines that serve patients in over 120 countries, with a global workforce of several thousand. ⁶ 

  Her mantra has been:

“I believe in never giving up, no matter what the odds. Failure is temporary. Giving up is permanent.” ⁷ 

Kiran’s work has earned her several recognitions, including the Padma Shri (1989) and Padma Bhushan (2005) in India, the Othmer Gold Medal (2014), Kiel Institute’s Global Economy Prize for Business (2014), the French Legion of Honour (2016), the Order of Australia (2020), and EY World Entrepreneur of the Year (2020). In 2004, Federation University awarded her an honorary Doctorate of Science in recognition of her outstanding contributions to biotechnology.

Kiran’s contributions to biotechnology, healthcare, and social impact have positioned her among the world’s most influential leaders. She holds key board positions at leading global institutions, including MIT Corporation, Memorial Sloan Kettering Cancer Center, National Academy of Engineering, Lincoln Center for the Performing Arts in the U.S., and the Court of Regents, Royal College of Surgeons of Edinburgh, UK.

As she leads Biocon as its executive chairperson, Kiran wants to be remembered as someone who made a difference to global healthcare through affordable innovation. ⁸ 

Her story shows how determination, vision, and courage to take risks can break through barriers, inspiring a new generation of women in science and business.

Acknowledgement:

This biography was written by Her Place Women’s Museum using publicly available sources in consultation with Biocon

Commemoration

Dr Kiran Mazumdar‑Shaw, a distinguished alumna of Federation University Ballarat, was honoured on 5 March 2015 with the unveiling of a road named after her at the Mt Helen Campus.  

The Kiran Mazumdar‑Shaw Scholarship was established at Federation University Ballarat, and awarded for the first time in 2017, supporting the next generation of aspiring scientists.⁹